WO1999047700A1 - Verfahren und vorrichtung zum nachweis einer nukleotidsequenz - Google Patents
Verfahren und vorrichtung zum nachweis einer nukleotidsequenz Download PDFInfo
- Publication number
- WO1999047700A1 WO1999047700A1 PCT/DE1999/000725 DE9900725W WO9947700A1 WO 1999047700 A1 WO1999047700 A1 WO 1999047700A1 DE 9900725 W DE9900725 W DE 9900725W WO 9947700 A1 WO9947700 A1 WO 9947700A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- molecule
- primer
- microtiter plate
- fluorophoric
- bound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
Definitions
- the invention relates to a method according to the preamble of claim 1. It also relates to a microtiter plate and a kit for performing the method.
- An amplification method is known from WO93 / 09250, in which a first primer is bound to a first phase.
- a second primer is labeled with a fluorophore dye. If a nucleotide sequence to be detected is present, the labeled second primer accumulates on the solid phase. - In order to be able to recognize a sufficiently discriminating signal on the solid phase, it is necessary to carry out a washing step after the PCR. This step requires additional work. Contamination can also occur.
- the object of the present invention is to eliminate the disadvantages of the prior art.
- a simple and inexpensive method with improved sensitivity and less contamination probability is to be specified.
- the concentration of the nucleotide sequence to be detected should be determinable as efficiently as possible.
- At least one of the fluorophoric molecules is bound to the surface of a solid phase.
- the method allows a qualitative and quantitative determination of the nucleotide sequence to be detected.
- simple fluorescence measurement in particular online detection, is possible.
- the process can be carried out simply and inexpensively because washing steps which increase the risk of contamination can be dispensed with.
- a first primer is bound to the solid phase.
- the first fluorophoric molecule may be bound to the solid phase via the first primer.
- the first primer advantageously has a hairpin loop, and the first fluorophoric molecule is bound to one loop section and the second fluorophoric molecule opposite to the other loop section at a distance that enables the interaction.
- the interaction is expediently eliminated by hybridization with a complementary strand complementary to the first primer or by a synthesis taking place on the first primer. The probability of contamination is further reduced by the aforementioned procedure.
- the second fluorophoric molecule can also be bound to a second primer.
- a second primer is in solution.
- the first and second primers are advantageously hybridized in such a way that the interaction is generated.
- the distance between the first and second fluorophoric molecules is preferably 2 to 12 nucleotides.
- the solid phase can contain a, preferably electrically conductive, plastic, for example a polycarbonate, polycarbene, trimethylthiopene and / or triaminobenzene and / or carbon fibers. It has proven to be particularly advantageous that the solid phase is a microtiter plate.
- the first molecule is an acceptor group and the second fluorophoric molecule is a donor group.
- the acceptor group can be a 6-carboxy-tetramethyl-rhodamine and the donor group can be a 6-carboxy-fluorescein.
- Other suitable donor / acceptor pairs are shown in the table below:
- IAEDANS 5 - ((((2-fluorescein iodoacyl) amino) ethyl) amino) nap hathalene-isulonic acid)
- first and second fluorophoric molecules can be interchanged.
- the first or second fluorophoric molecule can be replaced by a quencher, preferably formed from 4- [4 '-dimethylaminophenylazo] benzene acid.
- the fluorescence can be detected by means of a fluorometer connected to a data processing device, the concentration of the nucleotide sequence to be detected being determined from the change in the fluorescence intensity over time.
- the second derivative of the fluorescence intensity over the number of amplification cycles carried out is preferably used as the reference point.
- a microtiter plate with a top side having several trough-shaped depressions is provided for carrying out the method according to the invention, to which the first molecule is bound.
- a first primer can be bound to the top side, the first molecule advantageously being bound to the surface via the first primer.
- the first primer has a hairpin loop, and the first molecule is bound to a loop section and the second molecule opposite to a second loop section at a distance that enables the interaction.
- a kit with a microtiter plate according to the invention and a primer provided with a second molecule is provided.
- 7b the particle according to FIG. 7a in a fluorescence microscope image
- 7c shows a particle bound to a second primer after a PCR without template DNA in a dark field image
- a first primer P1 is bound to the top inside a cavity of a microtiter plate M made of polycarbonate or polypropylene.
- the microtiter plate M can contain a controlled resistance heater. It can also be a resistance heating element itself.
- a first fluorophore molecule F1 is bound to the first primer P1.
- the nucleic acid sequence N to be detected contained in a target DNA and the further components necessary for carrying out a polymerase chain reaction (PCR) or ligase chain reaction (LCR) are pipetted into the cavities. These contain in particular a second primer P2 with a second fluorophore molecule F2 bound to it.
- PCR polymerase chain reaction
- LCR ligase chain reaction
- the target DNA is denatured by increasing the temperature, i.e. separated into a strand S and a counter strand G.
- the temperature is then reduced to 50 to 60 °.
- the strand S binds to the first primer P1 with a complementary sequence section.
- the counter strand G binds to the second primer P2 in the liquid.
- the missing sequence section is then synthesized using a Taq DNA polymerase. Then the temperature is raised to 94 ° C., so that the synthesis strands containing the fluorophoric molecules F1, F2 as single strands, namely as synthesis strand SSI and as synthesis counter strand SGI, in the 8th
- the second fluorophoric molecule F2 can also be incorporated into the synthesis strand SSI bound to nucleotides or a further nucleic acid sequence.
- the temperature is reduced to 50 to 60 °.
- the synthesis strand SSI and the synthesis counter strand SGI hybridize so that the first F1 and the second fluorophore molecule F2 are at a distance of 6 to 12 nucleotides.
- Fig. 2 shows this schematically.
- the first fluorophoric molecule F1 which is designed as a donor
- the second fluorophoric molecule F2 which acts as an acceptor.
- an increased fluorescence is observed on the second fluorophoric molecule F2.
- the fluorescence is detected using a fluorometer. The detected values are forwarded to a data processing system.
- the first primer P1 can also have a hairpin loop, the first fluorophore molecule F1 being bound to a first loop section and a quencher opposite to a loop section at a distance which enables the interaction.
- the hairpin loop is closed, the interaction causes the fluorescence to be quenched.
- the hairpin loop is opened by hybridization with a counter strand G complementary to the first primer P1 or by a synthesis taking place on the first primer P1.
- the interaction between the fluorophore molecule and the quencher is broken. When the fluorophoric molecules are excited, fluorescence occurs.
- the next PCR cycle is then initiated by increasing the temperature. This leads to a further increase in the Synthesis strand SSI and the synthesis counter strand SGI and consequently to an increase in the fluorescence intensity.
- the change in the fluorescence intensity over the number of PCR or LCR cycles is a measure of the initial concentration of the target DNA: the more target DNA is contained in a sample, the faster the fluorescence intensity increases.
- a microtiter plate M made of polycarbonate or polypropylene is used to carry out the aforementioned method.
- the first primer P1 is bound to a polypropylene surface with its 5 'end via a linker, which preferably consists of 6 CH 2 groups.
- the first primer P1 is bound to the polypropylene surface by the method of Weiler-J. and Hoheisel-JD. (Anal. Biochem., 1996; 243 (2): 218-27).
- the first fluorophore molecule F1 is directly attached to the solid phase, i.e. the top of the microtiter plate M, bound.
- the first primer P1 is bound to the solid phase in the vicinity of the first fluorophoric molecule F1.
- After a hybridization of the synthesis strands SSI or the synthesis counterstrands SGI when there is an excitation, there is a radiation-free energy transition from the first fluorophoric molecule F1 (donor) to the second fluorophore molecule F2 (acceptor) and fluorescence there (FIG. 5).
- FIG. 6 shows the fluorescence of PCR products of PCR with 3'-fluorophore-bearing primers.
- the fluorescence of the PCR product is at an excitation wavelength of 496 im 10
- the sample "PCR without template” is a PCR approach without HGH template DNA after 25 cycles.
- the sample “PCR with template” is a PCR approach with HGH template DNA after 25 cycles.
- the right column shows the PCR approach with template DNA, but without performing temperature cycles.
- Example 1 Fluorescence energy transfer in PCR products from 3'-fluorophore-bearing primers
- Two primers are synthesized which were labeled with fluorophoric groups in the region of the 3 'end.
- a first primer with a length of 23 bases has the following sequence:
- the thymidine at position 4 with respect to the 3 'end (printed in bold in the sequence) is labeled with 6-carboxyfluorescein (6-FAM).
- 6-carboxyfluorescein (6-FAM).
- the FAM group is linked via the amino group of the dT-C2-NH2 incorporated during the oligonucleotide synthesis.
- the thymidine at position 3 with respect to the 3 'end (printed in bold in the sequence) is marked with carboxymethylrhodamine (TAMRA).
- TAMRA carboxymethylrhodamine
- the TAMRA group is linked via the a ino group of the dT-C2-NH2 incorporated during oligonucleotide synthesis.
- the second primer is labeled with a biotin group at the 5 'end.
- the synthesis scale is 0.2 ⁇ mol.
- the primers are cleaned by HPLC.
- the sequences of the primers are located immediately adjacent to a sequence section of the human growth hormone gene (HGH gene).
- HGC 5'-ACCAGGAGTTTGTAAGCTCTTGG-GGAATGGGTGCGCATCAGG-3 '3' -TGGTCCTCAAACATTCGAGAACC-CCTTACCCACGCGTAGTCC-5 '
- Second primer 3 * -CCTTACCCACGCGTAGTCC-Biotin-5 '
- the first and second primers are reacted in a PCR using a template DNA covering the sequence portion of the HGH gene.
- the PCR is carried out in a total volume of 50 ⁇ l, each with 0.5 ⁇ M primer, 2 units of Taq DNA polymerase and 1 ⁇ l HGH gene (10ng) in the corresponding PCR buffers (all solutions and enzymes from Boehringer, Mannheim). 25 cycles with an annealing temperature of 66 ° C (45 seconds), elongation temperature of 72 ° C (45 seconds) and a denaturation temperature of 94 ° C (30 seconds) are carried out. 12
- the same PCR is carried out, leaving out the template DNA.
- the PCR mixture is left at 4 ° C.
- the PCR forms a PCR product in which the fluorophores of the first and second primers are arranged at a distance of a few bases on the strands of opposite polarity:
- the fluorescence is determined in a fluorescence spectrometer with an excitation of 496nm (+/- 10nm) and an emission of 576n (+/- 10nm).
- the fluorescence of the TAMRA group is increased by the PCR (FIG. 6). This increase in fluorescence indicates the formation of the expected PCR product. 13
- Example 2 The same primers described in Example 1 are used for the PCR with 3 '-labelled and immobilized primers.
- the 5 '-biotinylated second primer according to Example 1 is bound by the PCR to streptavidin-coated, super-paramagnetic particles with a size of approximately 2.8 ⁇ m in diameter (M-280 Dynabeads, Dynal, Hamburg).
- the particles (10 ⁇ g / ⁇ l; 6.7 x 10 8 particles / ml suspended in phosphate buffered saline (PBS) pH 7.4 with B / W buffer (10 mm Tris-Cl, ImM EDTA, 2M NaCl) pH 7 , 5 and brought to a concentration of 5 ⁇ g / ⁇ l in B / W buffer
- B / W buffer 10 mm Tris-Cl, ImM EDTA, 2M NaCl
- TE lOmM TrisCl, 0.2mM EDTA pH8
- the PCR according to Example 1 is carried out with the second primer bound to the supermagnetic particle.
- 1 ⁇ l of the suspension of particle-bound primer-2 is used instead of the free second primer.
- the particles are washed several times in TE and analyzed in a fluorescence microscope. The attachment of the 6-FAM-labeled first primer to the particles is examined. 7A shows the fluorescence of the particles after completion. A fluorescence of the particles can be observed in the PCR approach shown in FIG. 7B. 14
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000536883A JP2002506654A (ja) | 1998-03-18 | 1999-03-16 | ヌクレオチド配列を検出するための方法と装置 |
CA002323075A CA2323075A1 (en) | 1998-03-18 | 1999-03-16 | Method and device for detecting a nucleotide sequence |
EP99919084A EP1064407A1 (de) | 1998-03-18 | 1999-03-16 | Verfahren und vorrichtung zum nachweis einer nukleotidsequenz |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19811729.9 | 1998-03-18 | ||
DE19811729A DE19811729C2 (de) | 1998-03-18 | 1998-03-18 | Verfahren und Vorrichtung zum Nachweis einer Nukleotidsequenz |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999047700A1 true WO1999047700A1 (de) | 1999-09-23 |
Family
ID=7861305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1999/000725 WO1999047700A1 (de) | 1998-03-18 | 1999-03-16 | Verfahren und vorrichtung zum nachweis einer nukleotidsequenz |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1064407A1 (ja) |
JP (1) | JP2002506654A (ja) |
CA (1) | CA2323075A1 (ja) |
DE (1) | DE19811729C2 (ja) |
WO (1) | WO1999047700A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19960076C2 (de) * | 1999-12-13 | 2002-12-05 | November Ag Molekulare Medizin | Verfahren und Vorrichtung zum Nachweis und zur Quantifizierung von Biomolekülen |
WO2013055647A1 (en) | 2011-10-11 | 2013-04-18 | Enzo Life Sciences, Inc. | Fluorescent dyes |
US9068948B2 (en) | 2002-03-12 | 2015-06-30 | Enzo Life Sciences, Inc. | Processes for detection of nucleic acids |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
CN112996899A (zh) * | 2018-11-09 | 2021-06-18 | 横河电机株式会社 | 核酸序列检测用装置 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10111420A1 (de) * | 2001-03-09 | 2002-09-12 | Gnothis Holding Sa Ecublens | Bestimmung von Analyten durch Fluoreszenz-Korrelationsspektroskopie |
JP4710283B2 (ja) * | 2004-09-08 | 2011-06-29 | 富士レビオ株式会社 | 核酸配列の増幅法および検出法 |
US7955802B2 (en) | 2006-12-13 | 2011-06-07 | Luminex Corporation | Systems and methods for multiplex analysis of PCR in real time |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996143A (en) * | 1985-12-23 | 1991-02-26 | Syngene, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization |
WO1993009250A1 (en) * | 1991-11-01 | 1993-05-13 | Adelaide Children's Hospital | Solid phase amplification process |
EP0745690A2 (en) * | 1995-05-12 | 1996-12-04 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide Probes, Assays and Kits |
US5607834A (en) * | 1992-12-10 | 1997-03-04 | Maine Medical Center Research Institute | Fluorescent imperfect hairpin nucleic acid probes |
WO1997022719A1 (en) * | 1995-12-18 | 1997-06-26 | Washington University | Method for nucleic acid analysis using fluorescence resonance energy transfer |
WO1997031256A2 (en) * | 1996-02-09 | 1997-08-28 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
DE29521620U1 (de) * | 1994-02-01 | 1997-11-13 | The Regents Of The University Of California, Berkeley, Calif. | Fluoreszierende Marker und diese enthaltender Reagenzsatz |
WO1997046714A1 (en) * | 1996-06-04 | 1997-12-11 | University Of Utah Research Foundation | Monitoring hybridization during pcr |
US5723591A (en) * | 1994-11-16 | 1998-03-03 | Perkin-Elmer Corporation | Self-quenching fluorescence probe |
-
1998
- 1998-03-18 DE DE19811729A patent/DE19811729C2/de not_active Expired - Fee Related
-
1999
- 1999-03-16 CA CA002323075A patent/CA2323075A1/en not_active Abandoned
- 1999-03-16 WO PCT/DE1999/000725 patent/WO1999047700A1/de not_active Application Discontinuation
- 1999-03-16 JP JP2000536883A patent/JP2002506654A/ja not_active Withdrawn
- 1999-03-16 EP EP99919084A patent/EP1064407A1/de not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996143A (en) * | 1985-12-23 | 1991-02-26 | Syngene, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization |
WO1993009250A1 (en) * | 1991-11-01 | 1993-05-13 | Adelaide Children's Hospital | Solid phase amplification process |
US5607834A (en) * | 1992-12-10 | 1997-03-04 | Maine Medical Center Research Institute | Fluorescent imperfect hairpin nucleic acid probes |
DE29521620U1 (de) * | 1994-02-01 | 1997-11-13 | The Regents Of The University Of California, Berkeley, Calif. | Fluoreszierende Marker und diese enthaltender Reagenzsatz |
US5723591A (en) * | 1994-11-16 | 1998-03-03 | Perkin-Elmer Corporation | Self-quenching fluorescence probe |
EP0745690A2 (en) * | 1995-05-12 | 1996-12-04 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide Probes, Assays and Kits |
WO1997022719A1 (en) * | 1995-12-18 | 1997-06-26 | Washington University | Method for nucleic acid analysis using fluorescence resonance energy transfer |
WO1997031256A2 (en) * | 1996-02-09 | 1997-08-28 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
WO1997046714A1 (en) * | 1996-06-04 | 1997-12-11 | University Of Utah Research Foundation | Monitoring hybridization during pcr |
Non-Patent Citations (3)
Title |
---|
JU J ET AL: "DESIGN AND SYNTHESIS OF FLUORESCENCE ENERGY TRANSFER DYE-LABELED PRIMERS AND THEIR APPLICATION FOR DNA SEQUENCING AND ANALYSIS", ANALYTICAL BIOCHEMISTRY, vol. 231, no. 1, 10 October 1995 (1995-10-10), pages 131 - 140, XP000536518, ISSN: 0003-2697 * |
NAZARENKO ET AL: "A CLOSED TUBE FORMAT FOR AMPLIFICATION AND DETECTION OF DNA BASED ENERGY TRANSFER", NUCLEIC ACIDS RESEARCH, vol. 25, no. 12, 1 January 1997 (1997-01-01), pages 2516 - 2521, XP002094959, ISSN: 0305-1048 * |
TYAGI S ET AL: "MOLECULAR BEACONS: PROBES THAT FLUORESCE UPON HYBRIDIZATION", BIO/TECHNOLOGY, vol. 14, 1 March 1996 (1996-03-01), pages 303 - 308, XP000196024, ISSN: 0733-222X * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19960076C2 (de) * | 1999-12-13 | 2002-12-05 | November Ag Molekulare Medizin | Verfahren und Vorrichtung zum Nachweis und zur Quantifizierung von Biomolekülen |
US10144957B2 (en) | 2002-03-12 | 2018-12-04 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
US9068948B2 (en) | 2002-03-12 | 2015-06-30 | Enzo Life Sciences, Inc. | Processes for detection of nucleic acids |
US9261460B2 (en) * | 2002-03-12 | 2016-02-16 | Enzo Life Sciences, Inc. | Real-time nucleic acid detection processes and compositions |
US9316587B2 (en) | 2002-03-12 | 2016-04-19 | Enzo Life Sciences, Inc. | Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
US9416153B2 (en) | 2011-10-11 | 2016-08-16 | Enzo Life Sciences, Inc. | Fluorescent dyes |
US10106573B2 (en) | 2011-10-11 | 2018-10-23 | Enzo Life Sciences, Inc. | Fluorescent dyes and methods of use thereof |
WO2013055647A1 (en) | 2011-10-11 | 2013-04-18 | Enzo Life Sciences, Inc. | Fluorescent dyes |
EP3747877A1 (en) | 2011-10-11 | 2020-12-09 | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. | Fluorescent dyes |
US10875886B2 (en) | 2011-10-11 | 2020-12-29 | Enzo Life Sciences, Inc. | Fluorescent dyes and methods of use thereof |
US11939350B2 (en) | 2011-10-11 | 2024-03-26 | Enzo Life Sciences, Inc. | Fluorescent dyes and methods of use thereof |
CN112996899A (zh) * | 2018-11-09 | 2021-06-18 | 横河电机株式会社 | 核酸序列检测用装置 |
CN112996899B (zh) * | 2018-11-09 | 2024-07-05 | 横河电机株式会社 | 核酸序列检测用装置 |
Also Published As
Publication number | Publication date |
---|---|
JP2002506654A (ja) | 2002-03-05 |
DE19811729A1 (de) | 1999-09-23 |
DE19811729C2 (de) | 2000-05-18 |
CA2323075A1 (en) | 1999-09-23 |
EP1064407A1 (de) | 2001-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69531133T2 (de) | Verfahren zur Dämpfung der Fluoreszene in Lösung von Fluoreszenzmarkierten Oligonucleotidsonden | |
DE60125243T2 (de) | Polynukleotid-sequenzassay | |
DE69816488T2 (de) | Pcr-primerkonstruktionen für ein integriertes signalsystem | |
DE60310532T2 (de) | Bestimmung von nukleinsäuren | |
DE602005000485T2 (de) | Nukleinsäurenachweisverfahren mittels mehreren Paaren von Donorflurophoren und Quenchemolekülen in derselben Sonde | |
DE69814848T2 (de) | Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden | |
WO2002038806A2 (de) | Nachweis von nukleinsäure-polymorphismen | |
EP2167685B1 (de) | Verfahren und sonden/primersystem zum "real time" nachweis eines nukleinsäuretargets | |
DE602004012273T2 (de) | Bestimmung der sequenz eines polynukleotids | |
DE60204874T2 (de) | Verfahren zur nachweis von nukleinsäuren | |
WO2018114674A1 (de) | Zweiteilige mediatorsonde | |
WO2001036668A1 (de) | Farbstoffmarkiertes oligonukleotid zum markieren eines nukleinsäuremoleküls | |
WO1999047701A1 (de) | Verfahren zum nachweis einer nukleotidsequenz | |
DE19811729C2 (de) | Verfahren und Vorrichtung zum Nachweis einer Nukleotidsequenz | |
DE60313828T2 (de) | Verfahren zum Nachweis von Nukleinsäuren mit Fluoreszenzfarbstoff-markierten Sonden welches auf der Analyse von Schmelzkurven basiert | |
DE69630517T2 (de) | Sonde zur Verwendung in der Nukleinsäurenanalyse und Detektionsverfahren auf der Basis von Excimer-Fluoreszenz | |
DE102007013099A1 (de) | Verfahren und Testkit zum schnellen Nachweis spezifischer Nukleinsäuresequenzen, insbesondere zum Nachweis von Mutationen oder SNP's | |
WO1999047702A2 (de) | Verfahren und vorrichtung zum identifizieren einer markierung | |
DE602006000713T2 (de) | Verfahren zur Verbesserung der Unterscheidung von einer einzelnen Basenfehlanpaarung durch die Verwendung von "hurdle" DNAs und Sonden mit artifiziellen Fehlpaarungen | |
WO2007110126A1 (de) | Verfahren zur mikroskopischen ortsbestimmung eines ausgewählten, intrazellulären dna-abschnitts bekannter nukleotidsequenz | |
DE60017750T2 (de) | Amplifizierungsverfahren zum Nachweis von zu bestimmenden Nucleinsäuren und Anwendung von Flourszenzenergieübertragung | |
DE19806962B4 (de) | Markierung von Nukleinsäuren mit speziellen Probengemischen | |
DE112016007245T5 (de) | Verfahren zum Nachweisen von Ziel-Nukleinsäuremolekülen | |
DE19858588B4 (de) | Farbstoffmarkiertes Oligonukleotid zum Markieren eines Nukleinsäuremoleküls | |
WO2012069484A2 (de) | Verfahren zum qualitativen und quantitativen nachweis von spezifischen nukleinsäuresequenzen in echtzeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999919084 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2323075 Country of ref document: CA Ref country code: CA Ref document number: 2323075 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09646303 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999919084 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999919084 Country of ref document: EP |